Symphony Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.27M Buy
24,387
+9,744
+67% +$2.16M 0.7% 42
2025
Q4
$3.36M Sell
14,643
-3,949
-21% -$900K 0.45% 56
2025
Q3
$4.23M Buy
18,592
+1,951
+12% +$397K 0.51% 49
2025
Q2
$2.81M Buy
16,641
+13,427
+418% +$2.5M 0.37% 62
2025
Q1
$558K Sell
3,214
-10,368
-76% -$2.02M 0.33% 54
2024
Q4
$2.34M Buy
13,582
+102
+0.8% +$18.8K 0.37% 60
2024
Q3
$2.63M Buy
13,480
+493
+4% +$92K 0.43% 57
2024
Q2
$2.19M Buy
12,987
+949
+8% +$157K 0.4% 59
2024
Q1
$2.19M Sell
12,038
-1,095
-8% -$189K 0.51% 51
2023
Q4
$2.12M Buy
13,133
+7,311
+126% +$1.07M 0.46% 56
2023
Q3
$823K Sell
5,822
-1,439
-20% -$211K 0.2% 85
2023
Q2
$967K Sell
7,261
-806
-10% -$118K 0.24% 81
2023
Q1
$1.27M Sell
8,067
-349
-4% -$53.4K 0.33% 62
2022
Q4
$1.38M Sell
8,416
-963
-10% -$148K 0.36% 58
2022
Q3
$1.34M Sell
9,379
-55
-0.6% -$7.89K 0.44% 55
2022
Q2
$1.45M Sell
9,434
-2,998
-24% -$458K 0.43% 49
2022
Q1
$2.15M Buy
12,432
+3,873
+45% +$563K 0.51% 42
2021
Q4
$1.16M Buy
8,559
+1,791
+26% +$212K 0.32% 67
2021
Q3
$737K Sell
6,768
-2,445
-27% -$279K 0.26% 67
2021
Q2
$1.04M Buy
9,213
+658
+8% +$74.1K 0.35% 56
2021
Q1
$902K Buy
8,555
+2,205
+35% +$236K 0.24% 69
2020
Q4
$669K Sell
6,350
-1,259
-17% -$121K 0.24% 74
2020
Q3
$666K Buy
7,609
+73
+1% +$6.87K 0.27% 61
2020
Q2
$740K Buy
7,536
+2,230
+42% +$196K 0.36% 47
2020
Q1
$399K Buy
+5,306
New +$452K 0.28% 59

Other funds holding ABBV